| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.1M | -34.4% |
| SG&A Expense | $3.5M | -43.6% |
| Operating Income | -$4.6M | +41.7% |
| Pre-tax Income | -$4.9M | +37.4% |
| Net Income | -$4.9M | +37.4% |
| EPS (Basic) | -$0.09 | +40.0% |
| EPS (Diluted) | -$0.09 | +40.0% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.1M | +13.3% |
| Short-term Investments | $5.0M | +0.0% |
| Current Assets | $8.4M | -32.1% |
| Total Assets | $9.7M | -29.4% |
| Current Liabilities | $118K | -30.4% |
| Total Liabilities | $118K | -30.4% |
| Stockholders' Equity | $9.6M | -29.4% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.6M | -36.9% |
| Capital Expenditures | $357K | +367.6% |
| Investing Cash Flow | $4.6M | +191.5% |
| Financing Cash Flow | $725K | +0.0% |
| Free Cash Flow | -$4.0M | -46.1% |